The online community for the biotech industry of the Netherlands.

Although the Netherlands biotechnology sector is not as large as some of Europe’s leaders, they are still making a name for themselves. NederlandBio has become a successful European Hotbed Community. Part of the Netherlands’ success has been its highly educated population and large scientific community. The amount of venture capital in NederlandBio has contributed to its status as a contender among larger biotechnology markets. NederlandBio is expected to continue flourishing and increasing its influence in the global biopharmaceutical sector.

Join the World Discussion Forum


Hotbed News
Oxyrane Raises $26.5 Million in Series D Financing Thursday, September 18, 2014
ProQR Therapeutics B.V. (PRQR) Prices IPO At $13 A Share Thursday, September 18, 2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office Thursday, September 18, 2014
ProSensa Holding N.V. (RNA) Announces Commencement Of Re-Dosing Of Drisapersen In North America In Patients With Duchenne Muscular Dystrophy Thursday, September 18, 2014
Biotech Venture Capital Firm Aglaia Launches New $65 Million Oncology Fund Thursday, September 18, 2014
ProSensa Holding N.V. (RNA) Announces Commencement Of Re-Dosing Of Drisapersen In North America In Patients With Duchenne Muscular Dystrophy Thursday, September 18, 2014
Galen Signs Exclusive Deal in Europe Tuesday, September 16, 2014
Your Brain On Snacks: Brain Stimulation Affects Craving And Consumption, University Of Waterloo Study Tuesday, September 16, 2014
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment Tuesday, September 16, 2014
Agendia BV Test For Molecular Subtyping Of Breast Cancer Is A Better Guide To Pre-Surgical Treatment, Study Finds Monday, September 15, 2014
12345678910